fentanyl (Mezolar Matrix®)

Status: Medicine does not meet criteria for AWMSG assessment
Excluded from appraisal by AWMSG as meets exclusion criteria 4. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.
Medicine details
Medicine name	fentanyl (Mezolar Matrix®)
Formulation	12 mcg/hr, 25 mcg/hr, 37.5 mcg/hr, 50 mcg/hr, 75 mcg/hr and 100 mcg/hr transdermal patch
Reference number	2603
Indication	Adults: Severe chronic pain which can be adequately managed only with opioid analgesics. Children: Long term management of severe chronic pain in children receiving opioid therapy from 2 years of age
Company	Sandoz Ltd
BNF chapter	Central nervous system
Assessment type	N/A
Status	Medicine does not meet criteria for AWMSG assessment
Date of issue	19/12/2014